- Home
- SHOT vs CASI Comparison
SHOT vs CASI Comparison
Compare SHOT & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHOT
- CASI
- Stock Information
- Founded
- SHOT 2018
- CASI 1991
- Country
- SHOT United States
- CASI China
- Employees
- SHOT N/A
- CASI N/A
- Industry
- SHOT Biotechnology: Pharmaceutical Preparations
- CASI Biotechnology: Pharmaceutical Preparations
- Sector
- SHOT Health Care
- CASI Health Care
- Exchange
- SHOT Nasdaq
- CASI Nasdaq
- Market Cap
- SHOT 30.4M
- CASI 29.7M
- IPO Year
- SHOT 2020
- CASI 1996
- Fundamental
- Price
- SHOT $0.26
- CASI $1.90
- Analyst Decision
- SHOT
- CASI Strong Buy
- Analyst Count
- SHOT 0
- CASI 1
- Target Price
- SHOT N/A
- CASI $4.00
- AVG Volume (30 Days)
- SHOT 3.8M
- CASI 7.1K
- Earning Date
- SHOT 05-15-2025
- CASI 05-16-2025
- Dividend Yield
- SHOT N/A
- CASI N/A
- EPS Growth
- SHOT N/A
- CASI N/A
- EPS
- SHOT N/A
- CASI N/A
- Revenue
- SHOT $573,336.00
- CASI $31,368,000.00
- Revenue This Year
- SHOT N/A
- CASI N/A
- Revenue Next Year
- SHOT N/A
- CASI N/A
- P/E Ratio
- SHOT N/A
- CASI N/A
- Revenue Growth
- SHOT 69.32
- CASI 8.39
- 52 Week Low
- SHOT $0.25
- CASI $1.64
- 52 Week High
- SHOT $1.77
- CASI $7.67
- Technical
- Relative Strength Index (RSI)
- SHOT 24.69
- CASI 54.27
- Support Level
- SHOT $0.25
- CASI $1.82
- Resistance Level
- SHOT $0.45
- CASI $1.92
- Average True Range (ATR)
- SHOT 0.06
- CASI 0.10
- MACD
- SHOT -0.02
- CASI 0.01
- Stochastic Oscillator
- SHOT 3.24
- CASI 91.74
About SHOT Safety Shot Inc.
Safety Shot Inc is a wellness and functional beverage company. It is set to launch Safety Shot, the patented beverage that helps people feel faster by reducing blood alcohol content and boosting clarity.
About CASI CASI Pharmaceuticals Inc.
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.